Skip to main content

Corporate insider profile

Lynn Seely Insider Trades

Lynn Seely has reported no open-market purchases on SEC Form 4 and is a net seller of $170,625 across 1 company. The most recent open-market transaction was reported on Nov 10, 2026. Source: SEC Form 4 filings.

Latest reported as President and CEO of Lyell Immunopharma, Inc. (LYEL).

SEC-reported filing activity is provided for research purposes and is not investment advice.

Purchase filings
0
Reported companies
1
Net open-market value
-$170,624.59
Latest transaction
Nov 10, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Nov 10, 2026Lyell Immunopharma, Inc. (LYEL)President and CEOSale545$15.93$8,682
Aug 21, 2026Lyell Immunopharma, Inc. (LYEL)President and CEOSale9,589$15.54$149,013
Aug 10, 2026Lyell Immunopharma, Inc. (LYEL)President and CEOSale390$14.34$5,593
May 11, 2026Lyell Immunopharma, Inc. (LYEL)President and CEOSale388$18.91$7,337

Common questions

Lynn Seely insider trading FAQ

Is Lynn Seely buying or selling stock?
Across all SEC Form 4 open-market filings on record, Lynn Seely is a net seller of $170,625, with no open-market purchases reported. The latest transaction was reported on Nov 10, 2026.
Which companies does Lynn Seely report insider trades for?
Lynn Seely has reported open-market trades in Lyell Immunopharma, Inc. (LYEL). The latest SEC-reported relationship is President and CEO of Lyell Immunopharma, Inc. (LYEL).
Where does Lynn Seely's insider trading data come from?
Watch Insiders reads the SEC Form 4 filings submitted to EDGAR under reporting owner CIK 1327111, and refreshes this page daily.